The role of RICTOR downstream of receptor tyrosine kinase in cancers.

The role of RICTOR downstream of receptor tyrosine kinase in cancers.
复制标题

DOI:
10.1186/s12943-018-0794-0
复制
发表时间:
2018-02-19
期刊:
影响因子:
37.3
通讯作者:
Dumaz N
Dumaz N
中科院分区:
医学1区
文献类型:
--
作者:
Jebali A;Dumaz N

文献摘要

参考文献

被引文献

相似文献

由磷脂酰肌醇-3-激酶(PI3K)、AKT和哺乳动物雷帕霉素靶标(MTOR)组成的受体酪氨酸激酶(RTK)下游网络的重要性早已为人所知,但RICTOR(雷帕霉素不敏感的mTOR伴侣)在这一途径中的核心作用才刚刚开始出现。Rictor对mTORC2(雷帕霉素复合体2的哺乳动物靶点)的激酶活性至关重要,因此在RTK下游起着关键作用。RICTOR的改变已经在许多类型的癌细胞中被发现,它在肿瘤发生中的作用最近开始被揭开。在这里,我们总结了关于RICTOR信号在癌症中的生物学的新研究,重点是RTK改变的肿瘤。我们发现,作为RTK的关键信号转导节点和关键效应器,RICTOR正在成为RTK改变的癌症治疗的一个有价值的靶点。
The importance of the network defined by phosphatidylinositol-3-kinase (PI3K), AKT and mammalian target of rapamycin (mTOR) downstream of Receptor Tyrosine Kinase (RTK) has been known for many years but the central role of RICTOR (rapamycin-insensitive companion of mTOR) in this pathway is only starting to emerge. RICTOR is critical for mTORC2 (the mammalian target of rapamycin complex 2) kinase activity and as such plays a key role downstream of RTK. Alterations of RICTOR have been identified in a number of cancer cell types and its involvement in tumorigenesis has begun to be unraveled recently. Here, we summarize new research into the biology of RICTOR signaling in cancers focusing on tumors with altered RTK. We show that, as a key signaling node and critical effector of RTKs, RICTOR is becoming a valuable therapeutic target in cancer with altered RTK.
DOI: 10.1126/scisignal.2004088
发表时间: 2013-04-02
期刊: Science signaling
影响因子: 7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者: Schultz N
DOI: 10.1158/2159-8290.cd-14-0971
发表时间: 2015-12
期刊: Cancer discovery
影响因子: 28.2
作者:
Cheng H;Zou Y;Ross JS;Wang K;Liu X;Halmos B;Ali SM;Liu H;Verma A;Montagna C;Chachoua A;Goel S;Schwartz EL;Zhu C;Shan J;Yu Y;Gritsman K;Yelensky R;Lipson D;Otto G;Hawryluk M;Stephens PJ;Miller VA;Piperdi B;Perez-Soler R
通讯作者: Perez-Soler R
DOI: 10.1038/onc.2009.198
发表时间: 2009-08
期刊: ONCOGENE
影响因子: 8
作者:
Gazdar, A. F.
通讯作者: Gazdar, A. F.
DOI: 10.1593/neo.10688
发表时间: 2010-09-01
期刊: NEOPLASIA
影响因子: 4.8
作者:
Hatanpaa, Kimmo J.;Burma, Sandeep;Habib, Amyn A.
通讯作者: Habib, Amyn A.
DOI: 10.1007/s10620-014-3417-7
发表时间: 2015-04-01
影响因子: 3.1
作者:
Kaibori, Masaki;Shikata, Nobuaki;Kon, Masanori
通讯作者: Kon, Masanori